Results 101 to 110 of about 116,934 (269)

Botulinum-Neurotoxin-A induzierte cholinerge Varikositäten im Caudatus-Putamen-Komplex der Maus: eine quantitative Studie [PDF]

, 2018
Nach intrastriataler Injektion von Botulinum-Neurotoxin-A in C57BL/6-Mäuse zeigten sich Botulinum-Neurotoxin-induzierte Varikositäten, kurz BiVs. Es wurden sowohl zeitliche als auch dosisabhängige Veränderungen der Chat-positiven Varikositätenvolumina ...
Spiewok, Juliane (gnd: 1161741976)
core   +1 more source

Epileptic–Dyskinetic Encephalopathy Associated with a PPP3CA Variant: Expansion of the Phenotypic Spectrum

Movement Disorders Clinical Practice, EarlyView.
Bruno Antunes Contrucci, Ursula Thomé, Larissa Aparecida Batista, Ana Laura Volpi Martins Lorenzoni, Carla Andrea Cardoso Tanuri Caldas, Americo Ceiki Sakamoto, Israel Gomy, Lisandra Mesquita Batista, Marcela Lopes de Almeida, Ana Paula Andrade Hamad, Guillermo Andrey Ariza Traslaviña   +10 more
wiley   +1 more source

HABIT‐ILE in young children with bilateral cerebral palsy in Benin: A randomized controlled trial

Developmental Medicine &Child Neurology, EarlyView.
Abstract Aim To investigate the efficacy of the Hand‐Arm Bimanual Intensive Therapy Including Lower Extremities (HABIT‐ILE) compared with usual physiotherapy delivered at the same dosage in children with bilateral cerebral palsy (CP) in Benin. Method This randomized controlled trial involved 32 children (19 males, 13 females) with bilateral CP, aged 2 ...
Emmanuel Segnon Sogbossi, Daniela Ebner‐Karestinos, Geoffroy Saussez, Julie Paradis, Solange H. Sotindjo Adon, Solange Dossou, Toussaint G Kpadonou, Rodrigo Araneda, Yannick Bleyenheuft   +8 more
wiley   +1 more source

Arrangement of the Clostridium baratii F7 toxin gene cluster with identification of a σ factor that recognizes the botulinum toxin gene cluster promoters.

PLoS ONE, 2014
Botulinum neurotoxin (BoNT) is the most poisonous substances known and its eight toxin types (A to H) are distinguished by the inability of polyclonal antibodies that neutralize one toxin type to neutralize any of the other seven toxin types.
Nir Dover, Jason R Barash, Julianne N Burke, Karen K Hill, John C Detter, Stephen S Arnon   +5 more
doaj   +1 more source

Combined dorsal and ventral rhizotomy in non‐ambulatory individuals with mixed spastic bilateral cerebral palsy: A prospective registry analysis

Developmental Medicine &Child Neurology, EarlyView.
This is the largest North American study of combined dorsal/ventral rhizotomy in non‐ambulatory, bilateral, mixed spastic–dyskinetic cerebral palsy (33 patients). Combined rhizotomy was safe, improved dystonia (Barry–Albright Dystonia Scale), spasticity (modified Ashworth scale), quality of life (Caregiver Priorities and Child Health Index of Life with
Adam C. Glaser, Joon Hyeok Choi, Kristin Buxton, Nahyun Kim, Juliana Mariani, Benjamin J. Shore, Weston T. Northam   +6 more
wiley   +1 more source

Treating chronic anal fissure with botulinum neurotoxin [PDF]

, 2004
Recent reports confirm that the management of chronic anal fissure has undergone extensive re-evaluation during the past few years. This rejuvenation of interest is attributable to the application of neurochemical treatment, which has contributed to the ...
Brisinda, D, Cadeddu, F, Brisinda, G, Maria, G., Brandara, F, CADEDDU, FEDERICA, Maria, G   +6 more
core   +2 more sources

Lysozyme gene treatment in testosterone induced benign prostate hyperplasia rat model and comparasion of its’ effectiveness with botulinum toxin injection

International Brazilian Journal of Urology
Objectives: To compare the effects and histopathological changes of botulinum neurotoxin type A and lysozyme gene injections into prostate tissue within a testosterone induced benign prostate hyperplasia rat model.
Osman Ergün, Pinar Aslan Koşar, İbrahim Onaran, Hakan Darici, Alim Koşar   +4 more
doaj   +1 more source

Genetically engineered red cells expressing single domain camelid antibodies confer long-term protection against botulinum neurotoxin

Nature Communications, 2017
A short half-life in the circulation limits the application of therapeutics such as single-domain antibodies (VHHs). We utilize red blood cells to prolong the circulatory half-life of VHHs.
Nai-Jia Huang, Novalia Pishesha, J. Mukherjee, Sicai Zhang, Rhogerry Deshycka, Valentino Sudaryo, M. Dong, C. Shoemaker, H. Lodish   +8 more
semanticscholar   +1 more source

Neuropsychiatric‐Led Presentation of Late‐Onset Parkin‐Related Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Sarah Fullam, Shane Lyons, Martha Finnegan, Richard Walsh, Sean O'Dowd   +4 more
wiley   +1 more source

BOTULINUM NEUROTOXIN-CLINICAL USES

, 2017
Introduction: Botulinum neurotoxin (BoNT) is produced by the spore-forming anaerobic bacterium Clostridium botulinum, which causes botulism. The symptoms of the disease are severe, expressed in tiredness, nausea and vomiting.
Tsankova, Dajana, Rostamloo, Mariya, Ermenlieva, Neli, Todorova, Tatina, Tsankova, Gabriela   +4 more
core   +1 more source